PartsTable
Technical Data Sheet
Download PDF

NDC00517-0955-01 — OLANZAPINE INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00517-0955-01: OLANZAPINE INJECTION.

The OLANZAPINE INJECTION is a the manufacturer industrial component. Key specifications include general_characteristics_item_description: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281608, part_name_assigned_by_controlling_agency: OLANZAPINE INJECTION 10MG VIAL. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-523-2406, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00517-0955-01
NSN: 6505-01-523-2406
FSC: 6505 — Drugs and Biologicals
CAGE: 7PXG8 — AMERICAN REGENT INC DBA AMERICAN REGENT, INC (USA)
SPECIFICATIONS
general_characteristics_item_descriptionAMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281608
part_name_assigned_by_controlling_agencyOLANZAPINE INJECTION 10MG VIAL
NSN6505-01-523-2406
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available OLANZAPINE INJECTION TITLE COMPONENT PN NDC00517-0955-01 MFR OLANZAPINE INJECTION
KEY FEATURES
•
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281608
TECHNICAL CHARACTERISTICS
GENERAL CHARACTERISTICS ITEM DESCRIPTIONAMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281608
SPECIAL FEATURESACTIVE INGREDIENT AND STRENGTH: OLANZAPINE 10 MG; ADMINISTRATION: INTRAMUSCULAR; USED FOR THE TREATMENT OF AGITATION ASSOCIATED WITH SCHIZOPHRENIA AND BIPOLAR MANIA; STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F); PROTECT FROM LIGHT, DO NOT FREEZE
PART NAME ASSIGNED BY CONTROLLING AGENCYOLANZAPINE INJECTION 10MG VIAL
SUBSTITUTES & CROSS-REFERENCES 2
ZYPREXAReference document
Same NSN cross-reference
Reference document — Secondary reference
04-1191Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC00517-0955-01?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00517-0955-01?
NDC00517-0955-01 is a OLANZAPINE INJECTION.
What parts can replace NDC00517-0955-01?
There are 2 known substitutes for NDC00517-0955-01: ZYPREXA, 04-1191. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00517-0955-01?
NDC00517-0955-01 is cataloged in the U.S. Government catalog under NSN 6505-01-523-2406. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00517-0955-01